{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:10:48Z","timestamp":1759936248049,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.vaccine.2021.01.026","type":"journal-article","created":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T07:55:17Z","timestamp":1611129317000},"page":"1051-1057","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Evaluation of safety and immunogenicity of feline vaccines with reduced volume"],"prefix":"10.1016","volume":"39","author":[{"given":"Dominique","family":"Jas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Frances-Duvert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Brunet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frantz","family":"Oberli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Michel","family":"Guigal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herv\u00e9","family":"Poulet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.vaccine.2021.01.026_b0005","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1748-5827.2007.00462.x","article-title":"Vaccination Guidelines Group (VGG) of the World Small Animal Veterinary Association (WSAVA). Guidelines for the vaccination of dogs and cats. Compiled by the Vaccination Guidelines Group (VGG) of the World Small Animal Veterinary Association (WSAVA)","volume":"48","author":"Day","year":"2007","journal-title":"J Small Anim Pract."},{"issue":"9","key":"10.1016\/j.vaccine.2021.01.026_b0010","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1177\/1098612X13500429","article-title":"2013 AAFP feline vaccination advisory panel report","volume":"15","author":"Scherk","year":"2013","journal-title":"J Feline Med Surg."},{"issue":"7","key":"10.1016\/j.vaccine.2021.01.026_b0015","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1177\/1098612X13489208","article-title":"ABCD: Update of the 2009 guidelines on prevention and management of feline infectious diseases","volume":"15","author":"Horzinek","year":"2013","journal-title":"J Feline Med Surg."},{"key":"10.1016\/j.vaccine.2021.01.026_b0020","doi-asserted-by":"crossref","unstructured":"M\u00f6stl K, Addie DD, Boucraut-Baralon C, Egberink H, Frymus T, Gruffydd-Jones T, et al.; European Advisory Board on Cat Diseases. Something old, something new: Update of the 2009 and 2013 ABCD guidelines on prevention and management of feline infectious diseases. J Feline Med Surg. 2015, 17(7):570\u201382.","DOI":"10.1177\/1098612X15588448"},{"issue":"3","key":"10.1016\/j.vaccine.2021.01.026_b0025","first-page":"111","article-title":"Cancer and comparative oncology","volume":"2","author":"Cats","year":"2015","journal-title":"Vet Sci."},{"issue":"7","key":"10.1016\/j.vaccine.2021.01.026_b0030","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1177\/1098612X15588451","article-title":"European Advisory Board on Cat Diseases. Feline injection-site sarcoma: ABCD guidelines on prevention and management","volume":"17","author":"Hartmann","year":"2015","journal-title":"J Feline Med Surg."},{"key":"10.1016\/j.vaccine.2021.01.026_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5402\/2011\/210982","article-title":"Origins of injection-site sarcomas in cats: the possible role of chronic inflammation","volume":"210982","author":"Woodward","year":"2011","journal-title":"ISRN Vet Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2021.01.026_b0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1098-612X(99)90005-0","article-title":"Current understanding of vaccination site-associated sarcomas in the cat","volume":"1","author":"Macy","year":"1999","journal-title":"J Feline Med Surg."},{"issue":"20","key":"10.1016\/j.vaccine.2021.01.026_b0045","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1016\/j.vaccine.2007.02.049","article-title":"A kinetic study of histopathological changes in the subcutis of cats injected with non-adjuvanted and adjuvanted multi-component vaccines","volume":"25","author":"Day","year":"2007","journal-title":"Vaccine."},{"issue":"5","key":"10.1016\/j.vaccine.2021.01.026_b0050","first-page":"126","article-title":"Veterinary products committee working group report on feline and canine vaccination","volume":"150","author":"Gaskell","year":"2002","journal-title":"Vet Rec."},{"issue":"4","key":"10.1016\/j.vaccine.2021.01.026_b0055","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jcpa.2015.08.007","article-title":"Swiss feline cancer registry: a retrospective study of the occurrence of tumours in cats in Switzerland from 1965 to 2008","volume":"153","author":"Graf","year":"2015","journal-title":"J Comp Pathol."},{"key":"10.1016\/j.vaccine.2021.01.026_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcpa.2018.06.008","article-title":"Feline injection site sarcomas: data from Switzerland 2009\u20132014","volume":"163","author":"Graf","year":"2018","journal-title":"J Comp Pathol."},{"issue":"5","key":"10.1016\/j.vaccine.2021.01.026_b0065","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2460\/javma.241.5.595","article-title":"Comparative vaccine-specific and other injectable-specific risks of injection-site sarcomas in cats","volume":"241","author":"Srivastav","year":"2012","journal-title":"J Am Vet Med Assoc"},{"issue":"4","key":"10.1016\/j.vaccine.2021.01.026_b0070","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/1098612X13505579","article-title":"Tail vaccination in cats: a pilot study","volume":"16","author":"Hendricks","year":"2014","journal-title":"J Feline Med Surg."},{"issue":"3","key":"10.1016\/j.vaccine.2021.01.026_b0075","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2460\/javma.234.3.376","article-title":"Temporal changes in characteristics of injection-site sarcomas in cats: 392 cases (1990\u20132006)","volume":"234","author":"Shaw","year":"2009","journal-title":"J Am Vet Med Assoc."},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2021.01.026_b0080","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1177\/106002809603000703","article-title":"Pain assessment of subcutaneous injections","volume":"30","author":"J\u00f8rgensen","year":"1996","journal-title":"Ann Pharmacother."},{"issue":"1","key":"10.1016\/j.vaccine.2021.01.026_b0085","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/1932296817735121","article-title":"Impact of injection speed, volume, and site on pain sensation","volume":"12","author":"Zijlstra","year":"2018","journal-title":"J Diabetes Sci Technol."},{"key":"10.1016\/j.vaccine.2021.01.026_b0090","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jcpa.2007.04.020","article-title":"Alternative early life vaccination programs for companion animals","volume":"137","author":"Poulet","year":"2007","journal-title":"J. Comp. Path."},{"key":"10.1016\/j.vaccine.2021.01.026_b0095","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ijpharm.2015.05.069","article-title":"Tolerability of hypertonic injectables","volume":"490","author":"Wang","year":"2015","journal-title":"Int J Pharm"},{"issue":"39","key":"10.1016\/j.vaccine.2021.01.026_b0100","article-title":"The how's and what's of vaccine reactogenicity","volume":"4","author":"Herv\u00e9","year":"2019","journal-title":"npj Vaccines"},{"issue":"7","key":"10.1016\/j.vaccine.2021.01.026_b0105","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/INF.0000000000002345","article-title":"Safety, tolerability and immunogenicity of an MF59-adjuvanted, cell culture-derived, A\/H5N1, subunit influenza virus vaccine: results from a dose-finding clinical trial in healthy pediatric subjects","volume":"38","author":"Chanthavanich","year":"2019","journal-title":"Pediatr Infect Dis J."},{"issue":"15\u201316","key":"10.1016\/j.vaccine.2021.01.026_b0110","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/S0264-410X(98)00461-7","article-title":"Safety and immunogenicity of a new formulation of an inactivated hepatitis A vaccine","volume":"17","author":"Dagan","year":"1999","journal-title":"Vaccine"},{"issue":"27","key":"10.1016\/j.vaccine.2021.01.026_b0115","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1016\/S0264-410X(01)00098-6","article-title":"Impact of osmolality on burning sensations during and immediately after intramuscular injection of 0.5 ml of vaccine suspensions in healthy adults","volume":"19","author":"Nony","year":"2001","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2021.01.026_b0120","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2460\/javma.231.1.94","article-title":"Adverse events after vaccine administration in cats: 2,560 cases (2002\u20132005)","volume":"231","author":"Moore","year":"2007","journal-title":"J Am Vet Med Assoc."},{"key":"10.1016\/j.vaccine.2021.01.026_b0125","first-page":"311","article-title":"Reaction rate in cats associated with a new controlled-titer feline panleukopenia-rhinotracheitis-calicivirus-Chlamydia psittaci vaccine","volume":"83","author":"Starr","year":"1993","journal-title":"Cornell Vet"},{"key":"10.1016\/j.vaccine.2021.01.026_b0130","unstructured":"Good veterinary pharmacovigilance practice guide. The European Animal Health Industry Good Practice Guide to veterinary Pharmacovigilance, 2nd edition April 2011, https:\/\/www.bft-online.de\/fileadmin\/bft\/publikationen\/GVPPGfinal_2011.pdf."},{"key":"10.1016\/j.vaccine.2021.01.026_b0135","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.tvjl.2008.05.025","article-title":"Onset of immunity in kittens after vaccination with a non-adjuvanted vaccine against feline panleucopenia, feline calicivirus and feline herpesvirus","volume":"182","author":"Jas","year":"2009","journal-title":"Vet J"},{"key":"10.1016\/j.vaccine.2021.01.026_b0140","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1136\/vr.162.21.690","article-title":"Compatibility between a rabies vaccine and a combined vaccine against feline rhinotracheitis, FCV, FPLV and FeLV, and Chlamydophila felis","volume":"162","author":"Guiot","year":"2008","journal-title":"Vet Rec"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21000426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21000426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:52:48Z","timestamp":1759402368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21000426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0264410X21000426"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.01.026","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of safety and immunogenicity of feline vaccines with reduced volume","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.01.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}